Passage Bio Q1 2026 Earnings Narrowerthanexpected loss signals disciplined spending FMC Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment EDAP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Operational Headwinds TOYO Q1 2026 Earnings Slight EPS Beat Fails to Lift Shares as Revenue Remains Undisclosed HPP Q1 2026 Earnings Loss Narrows on Surprise Beat but Stock Declines Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path